CovidVax

The latest info on
Covid-19 Vaccines

DistributionFull ListCategories

by Country by Vaccine
The vaccines in distribution, with the list of countries
Inactivatedstarted in December 2020
by Sinovac
Albania, Algeria, Armenia, Azerbaijan, Benin, Bosnia and Herzegovina, Brazil, Cambodia, Chile, China, Colombia, Djibouti, Dominican Republic, Ecuador, Egypt, El Salvador, Hong Kong, Indonesia, Laos, Libya, Malaysia, Mexico, North Macedonia, Northern Cyprus, Oman, Pakistan, Paraguay, Philippines, Somalia, Sudan, Tajikistan, Thailand, Timor, Tunisia, Turkey, Ukraine, Uruguay, Zimbabwe

Inactivatedstarted in December 2020
by Beijing Institute of BioProducts (Sinopharm)
Afghanistan, Algeria, Argentina, Bahrain, Bangladesh, Belarus, Belize, Bolivia, Brunei, Cambodia, Cameroon, Chad, China, Comoros, Congo, Djibouti, Dominica, Dominican Republic, Egypt, Equatorial Guinea, Gabon, Gambia, Guinea-Bissau, Hungary, Indonesia, Iran, Iraq, Jordan, Kyrgyzstan, Laos, Lebanon, Macao, Maldives, Mauritania, Mauritius, Moldova, Mongolia, Montenegro, Morocco, Mozambique, Myanmar, Namibia, Nepal, Niger, North Macedonia, Pakistan, Papua New Guinea, Paraguay, Peru, Senegal, Serbia, Seychelles, Sierra Leone, Somalia, Sri Lanka, Sudan, Syria, Trinidad and Tobago, Turkmenistan, United Arab Emirates, Venezuela, Vietnam, Zambia, Zimbabwe

Inactivatedstarted in December 2020
by Wuhan Institute of BioProducts (Sinopharm)
China, United Arab Emirates

Sputnik Vstarted in December 2020
by Gamaleya Research Institute
Albania, Algeria, Argentina, Armenia, Azerbaijan, Bahrain, Belarus, Bolivia, Bosnia and Herzegovina, Congo, Djibouti, Egypt, Ghana, Guinea, Guyana, Honduras, Hungary, India, Iran, Iraq, Jordan, Kazakhstan, Kenya, Kyrgyzstan, Laos, Lebanon, Libya, Mexico, Moldova, Mongolia, Montenegro, Nicaragua, North Macedonia, Oman, Pakistan, Palestine, Paraguay, Philippines, Russia, San Marino, Serbia, Sri Lanka, Syria, Tunisia, Turkmenistan, United Arab Emirates, Uzbekistan, Venezuela, Zimbabwe

mRNA Comirnatystarted in December 2020
by BioNTech + Pfizer
Afghanistan, Albania, Andorra, Aruba, Australia, Austria, Bahrain, Bangladesh, Belgium, Bermuda, Bhutan, Bolivia, Bonaire Sint Eustatius and Saba, Bosnia and Herzegovina, Brazil, Bulgaria, Canada, Cape Verde, Cayman Islands, Chile, Colombia, Costa Rica, Croatia, Curacao, Cyprus, Czechia, Denmark, Dominican Republic, Ecuador, El Salvador, England, Estonia, Faeroe Islands, Finland, France, French Polynesia, Germany, Gibraltar, Greece, Guernsey, Honduras, Hong Kong, Hungary, Iceland, Iraq, Ireland, Isle of Man, Israel, Italy, Japan, Jersey, Jordan, Kuwait, Laos, Latvia, Lebanon, Libya, Liechtenstein, Lithuania, Luxembourg, Macao, Malaysia, Maldives, Malta, Mexico, Moldova, Monaco, Mongolia, Montenegro, Netherlands, New Caledonia, New Zealand, North Macedonia, Northern Cyprus, Northern Ireland, Norway, Oman, Palestine, Panama, Peru, Philippines, Poland, Portugal, Qatar, Romania, Rwanda, San Marino, Saudi Arabia, Scotland, Serbia, Singapore, Sint Maarten (Dutch part), Slovakia, Slovenia, South Africa, South Korea, Spain, Sri Lanka, Sudan, Sweden, Switzerland, Tunisia, Turkey, Turks and Caicos Islands, Ukraine, United Arab Emirates, United Kingdom, United States, Uruguay, Vietnam, Wales

mRNA-1273started in January 2021
by Moderna + NIAID
Austria, Bangladesh, Belgium, Bhutan, Bonaire Sint Eustatius and Saba, Bulgaria, Canada, Congo, Croatia, Curacao, Cyprus, Czechia, Denmark, England, Estonia, Faeroe Islands, Finland, France, Germany, Greece, Greenland, Guatemala, Guernsey, Honduras, Hungary, Iceland, Indonesia, Ireland, Israel, Italy, Japan, Jersey, Latvia, Libya, Liechtenstein, Lithuania, Luxembourg, Malta, Netherlands, Northern Ireland, Norway, Palestine, Philippines, Poland, Portugal, Qatar, Romania, Rwanda, Scotland, Singapore, Sint Maarten (Dutch part), Slovakia, South Korea, Spain, Sri Lanka, Sweden, Switzerland, Taiwan, Ukraine, United Kingdom, United States, Vietnam, Wales

AZD 1222started in January 2021
by Oxford University + AstraZeneca
Afghanistan, Albania, Algeria, Andorra, Angola, Anguilla, Antigua and Barbuda, Argentina, Armenia, Australia, Austria, Azerbaijan, Bahamas, Bahrain, Bangladesh, Barbados, Belgium, Belize, Benin, Bermuda, Bhutan, Bolivia, Bosnia and Herzegovina, Botswana, Brazil, British Virgin Islands, Brunei, Bulgaria, Burkina Faso, Cambodia, Cameroon, Canada, Cape Verde, Cayman Islands, Central African Republic, Chile, Colombia, Comoros, Congo, Cook Islands, Costa Rica, Cote d'Ivoire, Croatia, Cyprus, Czechia, Democratic Republic of Congo, Djibouti, Dominica, Dominican Republic, Ecuador, Egypt, El Salvador, England, Estonia, Eswatini, Ethiopia, Falkland Islands, Fiji, Finland, France, Gambia, Georgia, Germany, Ghana, Greece, Grenada, Guatemala, Guernsey, Guinea-Bissau, Guyana, Haiti, Honduras, Hungary, Iceland, India, Indonesia, Iran, Iraq, Ireland, Isle of Man, Italy, Jamaica, Jersey, Jordan, Kenya, Kosovo, Laos, Latvia, Lebanon, Lesotho, Liberia, Libya, Lithuania, Luxembourg, Madagascar, Malawi, Malaysia, Maldives, Mali, Malta, Mauritania, Mauritius, Mexico, Moldova, Mongolia, Montenegro, Montserrat, Morocco, Mozambique, Myanmar, Namibia, Nauru, Nepal, Netherlands, Nicaragua, Niger, Nigeria, Niue, North Macedonia, Northern Cyprus, Northern Ireland, Oman, Pakistan, Palestine, Panama, Papua New Guinea, Paraguay, Peru, Philippines, Pitcairn, Poland, Portugal, Romania, Rwanda, Saint Helena, Saint Kitts and Nevis, Saint Lucia, Saint Vincent and the Grenadines, Samoa, Sao Tome and Principe, Saudi Arabia, Scotland, Senegal, Serbia, Seychelles, Sierra Leone, Sint Maarten (Dutch part), Slovakia, Slovenia, Solomon Islands, Somalia, South Korea, South Sudan, Spain, Sri Lanka, Sudan, Suriname, Sweden, Syria, Taiwan, Tajikistan, Thailand, Timor, Togo, Tonga, Trinidad and Tobago, Tunisia, Turkmenistan, Tuvalu, Uganda, Ukraine, United Arab Emirates, United Kingdom, Uruguay, Uzbekistan, Vanuatu, Vietnam, Wales, Wallis and Futuna, Yemen, Zambia

Covaxinstarted in January 2021
by Bharat Biotech
Central African Republic, Comoros, India, Iran, Mauritius, Paraguay

single-dose Ad26started in February 2021
by Janssen (Johnson & Johnson)
Afghanistan, Austria, Belgium, Brazil, Bulgaria, Cyprus, Czechia, Denmark, Estonia, France, French Polynesia, Germany, Greece, Haiti, Honduras, Hungary, Iceland, Ireland, Italy, Laos, Latvia, Libya, Lithuania, Malta, Mexico, Netherlands, Philippines, Poland, Portugal, Romania, South Africa, South Korea, Spain, United States

EpiVacCoronastarted in March 2021
by FBRI SRC VB VECTOR
Russia, Turkmenistan

Inactivated QazCovid-Instarted in April 2021
by Research Institute for Biological Safety Problems Republic of Kazakhstan
Kazakhstan

single-dose Ad5-nCoVstarted in May 2021
by CanSino Biologics + Beijing Institute of BioTech
Chile, China, Mexico, Pakistan

Latest updates about vaccines distribution:
Mar 11J&J announced that the European Commission has granted a Conditional Marketing Authorization for its vaccine
Mar 09Russia has signed a deal with Adienne Srl to produce Sputnik V vaccine in Italy planning to make 10 million doses this year
Mar 08Baxter BioPharma Solutions announced an agreement for fill/finish manufacturing of the company's vaccine in the US
Mar 04RDIF announced the approval of the Russian Sputnik V vaccine by the Ministry of Health of the Republic of Iraq
Mar 02Merck has entered into multiple agreements to support efforts to help produce J&J's COVID-19 vaccine
Mar 01Sputnik V vaccine against coronavirus has been given approval in the Slovak Republic
Feb 28J&J announced that the US' CDC Advisory Commitee has recommended the company's vaccine for individuals 18+
Feb 27FDA has issued Emergency Use Authorization for Janssen's vaccine to prevent COVID-19 in individuals 18 years of age and older
Feb 26J&J announced that the FDA and VRBPAC voted to recommend Emergency Use Authorization for the company's vaccine
Feb 24CanSinoBio announced that it has filed an application with NMPA for conditional marketing authorization of its Adenovirus vaccine


contact | about | ©2020 CovidVax.org project